Search research articles
Contact Us
Filters
Showing results (141-150 of 178) with videos related to
Page
of 18
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 18, 2006
Randomized phase II three-arm trial with three platinum-based doublets in metastatic non-small-cell lung cancer. An Italian Trials in Medical Oncology study
P Bidoli, N Zilembo, D Cortinovis, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
February 12, 1998
The aromatase inhibitor letrozole in advanced breast cancer: effects on serum insulin-like growth factor (IGF)-I and IGF-binding protein-3 levels
E Bajetta, L Ferrari, L Celio, et al.
Current Cancer Drug Targets
|
August 12, 2008
FHIT and p53 status and response to platinum-based treatment in advanced non-small cell lung cancer
D L Cortinovis, F Andriani, A Livio, et al.
Journal of Medical Ethics
|
October 2, 2008
Impact of recent legislative bills regarding clinical research on Italian ethics committee activity
L Porcu, D Poli, V Torri, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
February 17, 2001
The luteinising hormone-releasing hormone analogue triptorelin with or without the aromatase inhibitor formestane in premenopausal breast cancer: effects on bone metabolism markers
A Martinetti, L Ferrari, L Celio, et al.
International Journal of Oncology
|
April 29, 1998
Effects of short-term pre-operative tamoxifen on steroid receptor and Ki-67 expression in primary breast cancer: an immunocytochemical study
E Bajetta, L Celio, A Di Leo, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 1, 2000
Exemestane improves survival compared with megoestrol acetate in postmenopausal patients with advanced breast cancer who have failed on tamoxifen. results Of a double-blind randomised phase III trial
M Kaufmann, E Bajetta, L Y Dirix, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1996
Phase II study of vinorelbine in patients with pretreated advanced ovarian cancer: activity in platinum-resistant disease
E Bajetta, A Di Leo, L Biganzoli, et al.
British Journal of Cancer
|
May 6, 1998
FEP regimen (epidoxorubicin, etoposide and cisplatin) in advanced gastric cancer, with or without low-dose GM-CSF: an Italian Trial in Medical Oncology (ITMO) study
E Bajetta, M Di Bartolomeo, C Carnaghi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 17, 2009
Pemetrexed in combination with oxaliplatin as a first-line therapy for advanced gastric cancer: a multi-institutional phase II study
L Celio, C N Sternberg, R Labianca, et al.
Page
of 18
Search research articles
Search
Showing results (141-150 of 178) with videos related to
Sort By:
Page
of 18
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 18, 2006
Randomized phase II three-arm trial with three platinum-based doublets in metastatic non-small-cell lung cancer. An Italian Trials in Medical Oncology study
P Bidoli, N Zilembo, D Cortinovis, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
February 12, 1998
The aromatase inhibitor letrozole in advanced breast cancer: effects on serum insulin-like growth factor (IGF)-I and IGF-binding protein-3 levels
E Bajetta, L Ferrari, L Celio, et al.
Current Cancer Drug Targets
|
August 12, 2008
FHIT and p53 status and response to platinum-based treatment in advanced non-small cell lung cancer
D L Cortinovis, F Andriani, A Livio, et al.
Journal of Medical Ethics
|
October 2, 2008
Impact of recent legislative bills regarding clinical research on Italian ethics committee activity
L Porcu, D Poli, V Torri, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
February 17, 2001
The luteinising hormone-releasing hormone analogue triptorelin with or without the aromatase inhibitor formestane in premenopausal breast cancer: effects on bone metabolism markers
A Martinetti, L Ferrari, L Celio, et al.
International Journal of Oncology
|
April 29, 1998
Effects of short-term pre-operative tamoxifen on steroid receptor and Ki-67 expression in primary breast cancer: an immunocytochemical study
E Bajetta, L Celio, A Di Leo, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 1, 2000
Exemestane improves survival compared with megoestrol acetate in postmenopausal patients with advanced breast cancer who have failed on tamoxifen. results Of a double-blind randomised phase III trial
M Kaufmann, E Bajetta, L Y Dirix, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1996
Phase II study of vinorelbine in patients with pretreated advanced ovarian cancer: activity in platinum-resistant disease
E Bajetta, A Di Leo, L Biganzoli, et al.
British Journal of Cancer
|
May 6, 1998
FEP regimen (epidoxorubicin, etoposide and cisplatin) in advanced gastric cancer, with or without low-dose GM-CSF: an Italian Trial in Medical Oncology (ITMO) study
E Bajetta, M Di Bartolomeo, C Carnaghi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 17, 2009
Pemetrexed in combination with oxaliplatin as a first-line therapy for advanced gastric cancer: a multi-institutional phase II study
L Celio, C N Sternberg, R Labianca, et al.
Page
of 18